ERGIC-3, also known as Endoplasmic Reticulum-Golgi Intermediate Compartment protein 3, is a transmembrane protein that is hypothesized to play a role in the transportation and sorting of proteins between the endoplasmic reticulum (ER) and the Golgi apparatus. This pathway is critical for the proper processing, modification, and trafficking of proteins destined for secretion, inclusion in the cell membrane, or delivery to other organelles.The ER-Golgi intermediate compartment (ERGIC) functions as a sorting station where cargo proteins are selectively bundled into vesicles that will either move forward to the Golgi apparatus, return to the ER, or be shunted to other destinations. ERGIC-3, situated within this compartment, likely contributes to the recognition and binding of cargo proteins, playing a role in their correct sorting and packaging into transport vesicles.
Moreover, ERGIC-3 could be implicated in the maintenance of the structure and function of the ERGIC. It may interact with cytoskeletal elements and other ERGIC proteins to preserve the integrity and dynamics of the compartment, influencing vesicle formation, budding, and fusion processes.Although the exact molecular functions and interactions of ERGIC-3 are not fully elucidated, it is apparent that it is part of a complex network of proteins that ensure efficient cargo movement through the secretory pathway. Disruptions in the function of ERGIC-3 or its associated pathways can lead to diseases characterized by trafficking defects, including certain hereditary disorders and some types of neurodegenerative diseases.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus and can affect protein trafficking, potentially influencing ERGIC-3 function. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, impacting protein folding and trafficking in the ER and ERGIC, potentially affecting ERGIC-3. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis in the ER, affecting protein folding and processing, which could influence ERGIC-3. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that disrupts intracellular trafficking and endosomal sorting, potentially impacting ERGIC-3's role. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine can affect lysosomal degradation, which is interconnected with the secretory pathway, potentially impacting ERGIC-3. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to affect various cellular processes including protein trafficking, potentially influencing ERGIC-3. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase involved in regulating cell growth and protein synthesis, potentially affecting ERGIC-3. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $191.00 $683.00 | 11 | |
Golgicide A specifically targets the Golgi apparatus, disrupting Golgi function and potentially impacting ERGIC-3's role. | ||||||
15-Deoxy-δ12,14-Prostaglandin J2 | 87893-55-8 | sc-201262 sc-201262A | 1 mg 5 mg | $141.00 $551.00 | 5 | |
This compound can modulate ER stress responses, potentially impacting the function of ERGIC-3 in protein processing. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule dynamics, affecting cellular transport and potentially impacting ERGIC-3 function. | ||||||